Advertisement
Screener

Foamix Pharmaceuticals Ltd. Amended Reports

Foamix Pharmaceuticals Ltd. Amended Reports

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2018-03-01: Form 10-K/A; Period of report 2017-12-31; Description 10-K/A; Document zk1821314.htm.
FiledFormPeriod of reportDescriptionDocument
2018-03-0110-K/A2017-12-3110-K/Azk1821314.htm